Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance

Erscheinungsjahr 2022
ISBN: 978-0-323-90792-7
Verlag: Elsevier Inc

Buch, Englisch, 788 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 1334 g

Emerging Nanomaterials and Nano-based Drug Delivery Approaches to Combat Antimicrobial Resistance focuses on recent and emerging trends surrounding nanomaterials and nano-drug delivery approaches to combat antimicrobial resistance. The relationship between nanomaterials and antimicrobial activity needs to be deeply explored to meet the challenges of combating antimicrobial resistance. The content of this book is divided into three main topic areas, including (i) how to overcome the existing traditional approaches to combat antimicrobial resistance, (ii) applying multiple drug delivery mechanisms to target multi-drug resistant microbes, and (iii) how nanomaterials can be used as drug carriers.

This is an important reference source for those looking to understand how nanotechnology plays an important role in combatting disease and infection. As antimicrobial resistance threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses, and fungi, this is a timely resource.

Autoren/Hrsg.

Saravanan, Muthupandian

Barabadi, Hamed

J Webster, Thomas

Fachgebiete

• Technische Wissenschaften Maschinenbau | Werkstoffkunde Technische Mechanik | Werkstoffkunde Materialwissenschaft: Biomaterialien, Nanomaterialien, Kohlenstoff
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie

Inhaltsverzeichnis

1. Novel medicinal and synthetic chemistry strategies against antimicrobial resistance

2. Strategies of surface engineering/modifications for reversing antibiotic resistance

3. Overcoming antimicrobial resistance by nanoparticles
4. Nano-targeted drug delivery approaches for biofilm-associated infections

5. Nano-targeted drug delivery approaches for bacterial infections

6. Nano-structured drug delivery approaches for fungal infections

7. Nano-targeted drug delivery approaches for viral infections

8. Biogenic metal nanomaterials to combat antimicrobial resistance

9. Nanotechnology-based approaches against COVID-19

10. Nanotechnology-based approaches for antitubercular drug delivery

11. Nano-targeted drug delivery for parasitic infections

12. Nanovaccines delivery approaches against infectious diseases

13. Nanotechnology-based therapies for skin wound regeneration

14. Photodynamic therapy with nanomaterials to combat microbial infections

15. Application of extracellular vesicles in the diagnosis and treatment of infection and bacterial resistance

16. Aptamer-based nanomaterials for drug/gene delivery systems and diagnostics to combat microbial infections

17. Monoclonal antibodies for diagnostic and therapeutic systems to combat microbial infections

18. Nanoparticle-based antimicrobial for dental restorative materials

19. Toxicity and biocompatibility of nanomaterials: In vivo studies

20. Oligonucleotides: A therapeutic approach for tackling antimicrobial resistance

Über Autor(innen)

Barabadi, Hamed
Hamed Barabadi (PharmD, PhD) works as an assistant professor at the Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. He received a PhD degree from Shahid Beheshti University of Medical Sci-ences, Tehran, Iran, in 2019. He graduated as a Doctor of Pharmacy (PharmD) from Mazandaran University of Medical Sciences, Sari, Iran, in 2014. He owns to his credit a number of research papers, book chapters, and edited books with more than 3000 citations and h-index of 38. He has received many awards such as IET—Nanobiotech¬nology Premium Awards two times continuously in the years 2019 and 2020. Dr. Barabadi has been featured among the World’s Top 2% scientists list, according to a Stanford University study 2020 and 2022. He is the guest editor/editor for various reputed indexed journals such as Current Nanomedicine, Nanoscience and Nanotechnology-Asia, Frontiers in Pharmacology, MDPI International Journal of Molecular Sciences, MDPI Molecules, and a few other prestigious journals. His research interests lie in the area of pharmaceutical nanobiotechnology, ranging from green synthesis, characterization, and optimization of nanobiomaterials to their pharmaceutical potential evaluations, such as anticancer, antimicrobial, antioxidant, etc. Moreover, he has collaborated actively with researchers in several other disciplines of pharmaceutical sciences, particularly the nanoformulation of drugs for drug delivery systems and nanomedicine.

J Webster, Thomas
Dr. Thomas J. Webster is a pioneering professor in biomedical engineering, recognized for his leadership in academia and industry. His research focuses on applying nanotechnology to develop advanced materials for medical use, significantly improving healthcare outcomes. Dr. Webster has held prominent faculty positions in top U.S. and international universities, chaired departments, and directed international centers in biomaterials. He has also founded numerous companies translating his research into FDA-approved medical products. Widely published and a sought-after speaker, his work has been featured in major media outlets and science museums. Dr. Webster is renowned for organizing global conferences and symposia on nanomedicine and biomaterials, fostering interdisciplinary collaboration. He is the recipient of numerous prestigious awards and fellowships from leading scientific and medical organizations, demonstrating his impact and innovation in biomaterials, nanomedicine, and biomedical engineering.

Saravanan, Muthupandian
Dr. Muthupandian Saravanan is currently a Professor in the Department of Pharmacology at Saveetha University, SIMATS, Chennai, India. He has a degree in Microbiology from Madurai Kamaraj University and a Doctorate with Specialization in Medical Microbiology and Nanomedicine from Sathyabama University, India. As a Post-Doctoral Researcher at the Hebrew University of Jerusalem, he studied nano-biomaterials and their biomedical applications. He later worked as Associate Professor, under the United Nation Development Program in Department of Medical Microbiology and Immunology at Mekelle University in Ethiopia. He has published papers in high impact journals such as the Lancet and Nature. He has participated in more than 75 national and international conferences and reviewed of more than 100 international peer-reviewed journals. He has served as guest editor/ co-editor for reputed PubMed and Scopus indexed journals. He has received many fellowships and awards, notably the IET- Nanobiotechnology premium Awards in 2019 and 2020.